Osteonecrosis is a debilitating toxicity associated with acute lymphoblastic leukemia (ALL) treatment. A recent report associated interindividual differences in hip anatomy with the development of idiopathic osteonecrosis in adults. To evaluate the impact of hip anatomy on the development of therapy-related osteonecrosis, we retrospectively evaluated the femoral neck-shaft angle, femoral neck offset, and lateral center-edge angle using x-rays of 18 osteonecrosis cases and 46 control children treated for newly diagnosed ALL on a single protocol. Despite adequate statistical power, we found no association between hip anatomy and osteonecrosis. Investigation of other factors contributing to ALL-associated osteonecrosis is warranted.
TA B L E 1 Association of hip anatomy with clinical covariates and osteonecrosis risk
Values indicated are linear regression P values with hazard ratios (including 95% confidence intervals).
F I G U R E 1
Association of femoral neck shaft angle (NSA) with osteonecrosis. (A) NSA trended smaller with increasing age (P = 0.056). (B) Children who developed osteonecrosis had a trend toward smaller femoral NSAs than did controls (141°in cases vs. 143°in controls, P = 0.09), although there was considerable overlap between the groups. The association between NSA and osteonecrosis was further weakened when age was considered as a covariate (P = 0.11)
we evaluated the association of hip anatomy with the development of osteonecrosis in children treated for ALL.
RESULTS
All patients were treated for newly diagnosed ALL as part of Total Therapy Study XV (ClinicalTrials.gov, number NCT00137111). 1 With institutional review board's approval, patients with hip x-rays were identified through chart review. Because of their higher rate of osteonecrosis, 3, 5 our study focused on patients over the age of 10 years. Osteonecrosis of the femoral head was defined as femoral head lesions on MRI involving 30% or more of the epiphysis as previously described. 6 If multiple x-rays were available for a single patient, the one closest to the osteonecrosis-defining MRI was evaluated.
Anatomic measurements of the hip, including femoral neck-shaft angle (NSA), femoral neck offset (FNO), and lateral center-edge angle (LCEA), were performed as previously described 7,12,13 using two independent reviewers (M.V.P. and S.C.K.). All measurements were made using InteleViewer (Intelerad, Montreal, Quebec, Canada) with statistical analysis performed using R. 14 P values were obtained by linear or logistic regression as appropriate. Power analyses were performed in R using the "pwr" library and assumed previously demonstrated between-group differences would be replicated in our population.
Hip x-rays were available for 114 of 462 patients treated on protocol. After restricting our analysis to patients older than 10 years of age at the time of x-ray with available MRI evaluations of the hips, 18
had MR-demonstrated hip osteonecrosis and 46 served as unaffected controls. All x-rays taken on patients without osteonecrosis were taken to assess local pain. The patients were diagnosed at a median age of 13.8 and 12 years (P = 0.06) and had a median age of 14 and 14 years at the time of x-ray (P = 0.53) for cases and controls, respectively. There were 28 females and 36 males. Patients were primarily white (CEU >90% as determined by STRUCTURE, N = 49) 2,15 and male (N = 36). Fifty-four patients (including 15 cases) were treated with standard/high-risk therapy and 10 (three cases) with low-risk therapy.
Increasing age at the time of x-ray was associated with a greater FNO (P = 2.2×10 −5 ; Table 1 ). There was a trend toward smaller NSA with increasing age (P = 0.056; Fig. 1A ) and in females (P = 0.053).
There was no association between ancestry or protocol treatment arm (low vs. standard/high risk) and any anatomic measurement; LCEA was not associated with any patient characteristics (P > 0.05 for all variables).
There were no associations between the measured anatomic parameters and the development of hip osteonecrosis in our cohort (P = 0.2 for FNO, P = 0.09 for NSA [ Fig. 1B] , and P = 0.15 for LCEA [ Table 1] ). Because five patients had unilateral hip osteonecrosis, we evaluated intrapatient variability in hip measurements and found these to be less than interpatient variability. There was no trend toward a greater incidence of osteonecrosis in the more "high-risk" hip as defined by anatomical measurements. Because of the marginal P values associating anatomic parameters and osteonecrosis, we also evaluated the association of osteonecrosis with hip measurements in a multivariable analysis including age at the time of x-ray. Inclusion of age as a covariate further weakened the association between anatomic variability and osteonecrosis (P = 0.27 for FNO, P = 0.11 for NSA, and P = 0.17 for LCEA; Table 1 ).
DISCUSSION
Osteonecrosis has become a therapy-limiting side effect in recent pediatric ALL regimens. 5 Although factors such as age, 2,3,10,11 gender, 2, 10 ancestry, 2,10,11 and therapy intensity with dexamethasone 2 and asparaginase 10, 11 have been associated with the development of osteonecrosis, the interindividual variations resulting in osteonecrosis among patients remain incompletely understood. This is the first evaluation of associations between hip anatomy and therapy-related osteonecrosis in children with ALL. In contrast to published findings in adults with idiopathic osteonecrosis, 7 we identified no such association in our patient population, despite being adequately powered to identify the previously described differences in our population. At an alpha of 0.05 and coefficients of variation of 0.15, 0.03, and 0.15 for FNO, NSA, and LCEA, respectively, we had an 80% power to detect a difference in means between the cases and controls of 0.54 cm for the FNO, 3.29°for NSA, and 5.57°for LCEA, differences that are comparable to those previously reported. However, the differences we observed in FNO, NSA, and LCEA were all smaller than the withingroup differences among the cases or controls (Table 1 and Figs. 1A and 1B). This suggests that while hip anatomy contributes to excess risk of developing idiopathic osteonecrosis in adults, alternative factors drive the development of therapy-related osteonecrosis in children with ALL.
There are several limitations to our study related to its retrospective design. Because children with ALL do not routinely undergo x-rays of their hips during therapy, it is possible that the population with
x-rays performed does not represent the ALL population as a whole.
As we focused on patients older than 10 years of age at the time of
x-ray, these results should be applied only to that group. Additionally, because x-rays were taken in response to patient symptoms (either osteonecrosis or hip pain of other etiologies), patients were allowed to find positions of comfort while undergoing radiographs instead of being positioned in an identical pose. Due to skeletal immaturity, consistent identification of the needed landmarks was challenging.
These factors resulted in an increase in interreviewer variability in the measurements of hip anatomy. It is also possible that smaller anatomic differences than were previously shown 7 may contribute to the risk of osteonecrosis. If this is true, our study would be underpowered to detect such risk. However, even with the larger differences seen in our study, there is significant overlap between the anatomy of osteonecrosis cases and controls. This suggests that smaller differences would poorly discriminate between patients at standard or elevated risk of developing osteonecrosis, further arguing against prospective screening.
Although a prospective trial is the ideal setting to evaluate correlations between risk factors and therapy toxicity, our study suggests that prior knowledge of a patient's hip anatomy is unlikely to increase the ability to predict osteonecrosis during ALL therapy. Efforts to further minimize this side effect should focus on early detection 6 and an improved understanding of the pathophysiology through clinical and genomic studies.
